Series
Calendar: |
2/24/2009
|
Jonathan Vogel, MD |
The Identification and Characterization of Tumor-Initiating Cells in Human Squamous Cell Carcinoma of the Skin |
2/17/2009
|
Titia de Lange, PhD |
How Shelterin Protects Telomeres |
2/10/2009
|
Ola Langdon, MD, PhD |
Hematologic Malignancies and Their Precursors: An Area of Progression |
1/27/2009
|
Brigitte Widemann, MD |
Development of Targeted Therapies for Neurofibromatosis Type 1 Related Plexiform Neurofibromas |
1/6/2009
|
Malcolm K. Brenner, MD, PhD |
Implementing Cell and Gene Therapies for Cancer in an Academic Setting |
11/25/2008
|
Carol Estwing Ferrans, PhD |
Translation Science: Exposing a Deadly Difference |
11/18/2008
|
Cory Abate-Shen, PhD |
Modeling Cancer in Mice: Insights into Human Cancer |
11/4/2008
|
David Botstein, PhD |
How the Genome and the Computer Have Changed Our View of Cancer |
10/28/2008
|
David T. Scadden, MD |
The Stem Cell Niche |
10/21/2008
|
Howard A. Fine, MD |
Glioblastoma Initiating/Stem Cells: The Biological and Therapeutic Implications of a Changing Paradigm |
10/7/2008
|
J. Brice Weinberg, MD |
Nitric Oxide and Leukemia |
9/23/2008
|
Elise C. Kohn, MD |
Translational Trials and Tribulations |
9/16/2008
|
Malcolm K. Brenner, MD, MB, PhD, FRCP, FRCPath |
CANCELLED-Implementing Cell and Gene Therapies for Cancer in an Academic Setting |
7/1/2008
|
Snorri S. Thorgeirsson, MD, PhD |
Genomic Decoding of Liver Cancer: Mechanistic and Therapeutic Implications |
6/24/2008
|
Lisa M. Coussens, PhD |
Tissue-Specific Mechanisms Regulating Inflammation-Associated Epithelial Carcinogenesis |
6/10/2008
|
Bruce E. Johnson, MD |
Impact of Genomic Changes on the Treatment of Lung Cancr |
5/27/2008
|
Lee J. Helman, MD |
Recent Advances in Ewing's Sarcoma |
5/20/2008
|
Donald W. Kufe, MD |
Human MUC1-C Oncoprotein as a Target for Cancer Treatment |
5/13/2008
|
Pamela L. Schwarzberg, MD, PhD |
T Lymphocyte Signaling and Primary Immunodeficiencies: Lessons from X-linked Lymphoproliferative Disease |
5/6/2008
|
Xin Wei Wang, PhD |
Genomic Perspectives of Human Liver Cancer |
4/29/2008
|
A. Thomas Look, MD |
Dissecting Cancer Pathways using the Zebrafish: Autophagy and CHK1-Suppressed Apoptosis |
4/22/2008
|
Karen Dow Meneses, PhD, RN, FAAN |
Challenges and Explorations in Cancer Survivorship Research |
4/22/2008
|
Kenneth H. Kraemer,MD |
Xeroderma Pigmentosum: When the Lifeguard of the Gene Pool Goes on Strike |
4/8/2008
|
Giuseppe Giaccone, MD, PhD |
Targets and Targeted Therapy for Lung Cancer |
4/1/2008
|
Stephen B. Baylin, MD |
Gene Silencing and the Cancer Epigenome: Biology and Translational Implications |
3/25/2008
|
Francis S. Collins, MD, PhD |
The Cancer Genome Atlas Project |
3/18/2008
|
Stephen J. Elledge, PhD |
Adventures in Mammalian Genetics |
3/11/2008
|
Carl Wu, PhD |
Chromatin Architecture of Chromosome Centromere in Budding Yeast |
2/26/2008
|
Andrea Califano, Dr. |
Cancer Systems Biology Comes of Age: Using Molecular Interaction Networks to Dissect Master Regulators of Malignant Transformations |
2/19/2008
|
Donal Small, MD, PhD |
Targeting FLT3 for Novel Therapy of Leukemia |
2/12/2008
|
W. Marston Linehan, MD |
The Genetic Basis of Kidney Cancer: The Foundation for Disease-Based Therapy |
1/29/2008
|
Frank J. Gonzalez, PhD |
Mechanism of Action of Non-Genotoxic Chemical Carcinogens: Implications for Human Risk Assessment |
1/22/2008
|
Carl H. June, MD |
Adoptive Transfer Strategies: Impacting Tregs and Vaccines |
1/15/2008
|
Charles J. Sherr, MD PhD |
The ARF Tumor Suppressor: Role in Stem Cells, Aging and Cancer |
12/4/2007
|
Jay A. Berzofsky, MD, PhD |
The Pluripotential Abilities of IL-15 in Vaccines
|
11/27/2007
|
Catherine M. Handy, PhD, RN, AOCN |
The Future is Bright Yet so Small: Nanotechnology and Cancer Therapy |
11/20/2007
|
Ian F. Tannock, MD, PhD,FRCPC |
Limited Drug Distribution and Repopulation as Important and Neglected Causes of Drug Resistance in Solid Tumors |
11/13/2007
|
Jacques Banchereau, PhD |
Harnessing Dendritic Cells to Build Cancer Vaccines |
11/6/2007
|
Michael Dean, PhD |
Cancer, Inflammation, and Stem Cells |
10/30/2007
|
Mary Carrington, PhD |
The Influence of Variation at Immunogenetic Loci on Human Disease |
10/23/2007
|
Kenneth C. Anderson, MD |
Oncogenomics to Target Myeloma in the Bone Marrow Microenvironment |
10/16/2007
|
Isaiah J. Fidler, DVM, PhD |
Targeting the Organ Microenvironment for Treatment of Cancer Metastasis |
10/2/2007
|
Monica Justice, PhD |
Mouse Models of Hematologic Diseases |
6/26/2007
|
Barry Kramer, MD, MPH |
Lung Cancer Screening: What We Know vs.What Makes Sense |
6/19/2007
|
Thomas A. Waldmann, MD |
Passive and Active Immunotherapy of Cancer: A Critical Perspective |
6/12/2007
|
Anil K. Sood, MD |
Neuroendocrine Influences on Cancer Metastasis |
5/29/2007
|
Kevin A. Camphausen, MD |
Pre-clinical Models in Radiation Oncology |
5/22/2007
|
James L. Abbruzzese, MD, FACP |
Are There New Targets for Pancreatic Cancer Therapeutics? |
5/15/2007
|
Timothy R. Billiar, MD |
Liver Ischemia/Reperfusion as a Paradigm: Connecting Redox Biology to Inflammation and Organ Injury |
5/8/2007
|
Ronald A. DePinho, PhD |
Modeling and Mining Cancer Genomes |
5/1/2007
|
Stephen J. Elledge, PhD |
CANCELLED--The Phosphoproteomics of the DNA Damage Response |
4/24/2007
|
Merrill J. Egorin, MD, FACP |
The Relevance of Old-Fashioned Clinical Pharmacology to Modern Anticancer Chemotherapy |
4/17/2007
|
Jean Brown, PhD, RN, FAAN |
Symptom Management of Cancer-Related Nutritional Problems |
4/10/2007
|
Joan Brugge, PhD |
Modeling Cancer in 3 Dimensions |
4/3/2007
|
Katherine A. Jones, PhD |
Mechanistic Studies of RNAP II Transcription Elongation |
3/27/2007
|
William G. Nelson, MD, PhD |
5-Me-CpG-Binding Domain Proteins and PRostate Cancer Detection, Diagnosis, Prevention, and Treatment |
3/20/2007
|
Kevin Gardner, MD, PhD |
Genomic Approaches to Understanding Mechanisms of Gene Regulation: Perspectives from the Bench to the Bedside |
3/13/2007
|
Mina J. Bissell, PhD |
Context and Tissue Structure Determine The Pattern of Gene Expression and Phenotype in Normal and Malignant Breast |
3/6/2007
|
Zena Werb, PhD |
Deciphering the Tumor Microenvironment During Breast Cancer Progression |
2/27/2007
|
Monica Justice, PhD |
Mouse Models of Hematologic Diseases |
2/20/2007
|
Andre Nussenzweig, PhD |
Role of the DNA Damage Response in Maintaining Genome Stability |
2/13/2007
|
Merrill J. Egorin, MD, FACP |
The Relevance of Old-fashioned Clinical Pharmacology to Modern Anticancer Chemotherapy |
2/6/2007
|
Glenn Merlina, PhD |
Modeling the Genesis and Progression of Melanoma in the Mouse |
1/30/2007
|
Charlotte Kuperwasser, PhD |
The Use of Novel Zenograft Models to Study Stroma-epithelial Interactions in Breast Cancer |
1/23/2007
|
Margaret Shipp, MD |
Molecular Heterogeneity of Large B-Cell Lymphoma: Identificaation of Rational Treatment Targets |
1/16/2007
|
Carole A. Parent, PhD |
Gradient Sensing and Signal Relay During Chemotaxis |
12/12/2006
|
Mark Cushman, PhD Purdue University
Yves Pommier, MD, PhD NCI/CCR Lab of Medicinal Chemistry |
Synthesis and Evaluation of Indenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors: An NCI Intra-and Extra-Mural Partnership |
12/5/2006
|
J. Silvio Gutkind, PhD |
Head and Neck Cancer and Signaling Networks: Novel Mechanism-Based Therapies |
11/28/2006
|
Kenneth W. Kinzler |
Cancer Genomes: Discovery and Applications |
11/21/2006
|
Donald P. Bottaro, PhD |
The Role of Hepatocyte Growth Factor Signaling in Renal Cancer |
11/14/2006
|
Riccardo Dalla-Favera, MD |
CANCELLED--Novel Mechanisms of B-Cell Lymphoma Pathogenesis |
11/7/2006
|
Christine Miaskowski, RN, PhD, |
Symptom Clusters: The New Frontier in Symptom Management ResearchProfessor |
10/31/2006
|
John Barrett, MD |
How Can We Improve the Antileukemic Effect of Allogeneic Stem Cell Transplantation? |
10/24/2006
|
Lee M. Ellis, MD |
VEGF Biology: Beyond Angiogenesis |
10/10/2006
|
Peter J. Houghton, PhD |
The TOR Pathway in the Pathogenesis and Treatment of Cancer |
10/3/2006
|
Steven K. Libutti, MD |
Targeting the Tumor Microenvironment for Cancer Therapy |
9/26/2006
|
Javed Khan, MD |
Translational "omics" in Cancer |
9/19/2006
|
Samuel Strober, MD |
Harnessing the Power of Graft Anti-tumor Activity after Bone Marrow Transplantation |
9/12/2006
|
Steven M. Larson, MD |
Molecular Imaging and Targeted Radiotherapy in Oncology |
7/25/2006
|
Stuart Schreiber, PhD |
NCI's Initiative for Chemical Genetics |
7/18/2006
|
Giorgio Trinchieri, MD |
Toll-like Receptors and Cancer: Role in Inflammation, Proliferation, and Apoptosis |
7/11/2006
|
John Condeelis, PhD |
Mechanisms of Chemotaxis to EGF and How They Determine Metastatic Potential in Breast Cancer |
6/27/2006
|
Paul A. Bunn, Jr., MD |
EGFR Tyrosine Kinase Inhibitor for Lung Cancer: Patient Selection and Methods to Overcome Primary Resistance |
6/20/2006
|
Ron McKay, PhD |
Notch Signaling Regulates Stem Cell Numbers in Vitro and in Vivo |
5/30/2006
|
Allan Balmain, PhD, FRSE |
Mouse Models for the Identification of Human Tumor Susceptibility Genes |
5/23/2006
|
Timothy J. Triche, MD, PhD |
Genomic Analysis of Cancer: Improved Diagnosis and Treatment |
5/16/2006
|
Laurel Northouse, PhD,RN, FAAN |
The Importance of Families in Cancer Care |
5/2/2006
|
Chi V. Dang, PhD |
Global Genomic Mapping of the Myc Target Gene Network and Tumorigenesis |
4/25/2006
|
Louis J. Ignarro, Ph.D. |
Nitric Oxide as a Unique Signaling Molecule in Physiology |
4/18/2006
|
Samuel A. Wells, Jr., M.D. |
Targeted Therapy for Thyroid Cancer |
4/11/2006
|
Jeffrey N. Strathern, Ph.D. |
Palindromic Gene Amplifications--A New Model for Their Origin |
3/28/2006
|
Philip Beachy, PhD |
Hedgehog Signaling in Development and Disease |
3/21/2006
|
Timothy D. Veenstra, PhD |
Clinical Proteomics: From Discovery to Validation |
3/14/2006
|
Todd R. Golub, MD |
Genomic Signatures for Cancer Classification and Drug Discovery |
3/7/2006
|
Peter Greenwald, MD.,Dr.P.H. |
Clinical and Lifestyle Approaches to Cancer Prevention |
2/21/2006
|
Richard R. Love, MD |
The Case for a Paradigm Shift from Tumor to Host in Adjuvant Treatment of Breast Cancer |
2/14/2006
|
Anthony Atala, MD |
Regenerative Medicine: New Approaches to Health Care in the 21st Century |
2/7/2006
|
Ira Pastan, MD |
Immunotoxin Therapy of Cancer: Can Success in Treating Hairy Cell Leukemia be Extended to Other Cancers? |
1/31/2006
|
Clifton Leaf |
Cancer Epidemiology, Google, and the Dangerous Legacy of GIGO |
1/24/2006
|
Myles A. Brown, MD |
Genome-wide Analysis of Steroid Hormone Aaction |
1/17/2006
|
Thomas Misteli, PhD |
Beyond the Genome Sequence: Nuclear Architecture in Health and Disease |
11/29/2005
|
Richard M. Caprioli, PhD |
The Role of Proteomics in Clinical and Biological Research: Direct Tissue Analysis by Mass Spectrometry |
11/22/2005
|
Paul Meltzer, MD, PhD |
Using Genome Technologies to Find Biological Mechanisms in Cancer: Beyond Expression Profiling |
11/15/2005
|
Mark Levine, MD |
Ascorbic Acid In Humans: Tight Control and Unexpected Consequences for Cancer Therapy |
11/8/2005
|
Jeffrey M. Trent, PhD |
Towards Systems Medicine: Applications in Cancer Therapeutics |
11/1/2005
|
Sriram Subramaniam, PhD |
From Molecules to Tissues: Bridging the Imaging Gap with 3D Electron Microscopy |
10/25/2005
|
Angela Brodie, PhD |
Aromatase Inhibitors and Breast Cancer: Concept to Clinic |
10/11/2005
|
Phillip A. Sharp, PhD |
The Surprising Biology of Short RNAs |
10/4/2005
|
Pamela S. Hinds, PhD, PN, CS |
Fatigue in Adolescents with Cancer: From Clinical Complaint to Intervention |
9/27/2005
|
James B. Mitchell, PhD |
Chasing Free Radicals: Use of Nitroxide Antioxidants in Cancer Treatment and Prevention |
9/20/2005
|
James O. Armitage, MD |
Is Follicular Lymphoma A Curable Disease |
9/13/2005
|
Carlo M. Croce, MD |
MicroRNA Genes and Cancer |
7/26/2005
|
David H. Johnson, MD |
Targeting Inflammation in Non-Small Cell Lung Cancer |
7/19/2005
|
Max S. Wicha, MD |
Stem Cells in Normal Mammary Development and Breast Cancer |
7/12/2005
|
Crystal Mackall, MD |
Integrating Immunotherapy into Existing Cancer Therapies: Challenges and Opportunities |
6/28/2005
|
John D. Minna, MD |
Molecular Pathogenesis of Lung Cancer With Translation to the Clinic |
6/21/2005
|
Michael Karin, PhD |
The IKK Complex at the Crossroads of Inflammation and Cancer |
6/7/2005
|
Usha Menon, PhD, RN |
Literacy and Culture: Bridging Communication Gaps with Your Patients |
5/31/2005
|
Peter H. Duesberg, PhD |
Aneuploidy and Cancer: From Correlation to Causation |
5/24/2005
|
Sam T. Hwang, MD, PhD |
Chemokine Receptors in Organ-Selective Cancer Metastasis |
5/10/2005
|
James P. Allison, PhD |
Checkpoint Inhibition: A New Strategy for Tumor Immunotherapy |
5/3/2005
|
Curtis Harris, MD |
Chronic Inflammation and Cancer: Radical Causes of Human Cancer |
4/26/2005
|
John T. Schiller, PhD |
Recent Advances in Prophylactic HPV/Cervical Cancer Vaccines |
4/19/2005
|
John T. Schiller, PhD |
Recent Advances in Prophylactic HPV/Cervical Cancer Vaccines |
4/12/2005
|
Bruce E. Johnson, MD |
Impact of EGFR Mutations on the Treatment of Lung Cancer |
4/5/2005
|
Dan Theodorescu, MD, PhD |
RhoGDI2--A New Metastasis Suppressor in Bladder Cancer: Discovery and Clinical Translation |
3/29/2005
|
John D. Potter, MD, PhD |
Toward the Last Cohort |
3/22/2005
|
Kenneth C. Anderson, MD |
Targeting the Myeloma Cell in its Microenvironment |
3/15/2005
|
Cynthia Dunbar, MD- NHLBI
Neal G. Copeland, PhD-Mouse Cancer Genetics Program |
Of Mice and Monkeys: Stem Cell Immortalization Genes Unmasked |
3/8/2005
|
Peter M. Blumberg, PhD |
From Roadside to Bedside: Natural Products Providing a Path to Therapeutic Targets |
3/1/2005
|
Jeffrey S. Rubin, MD, PhD |
Keratinocyte Growth Factor: From Basic Research to Clinical Application |
2/22/2005
|
Andrew P. Feinberg, MD, MPH |
Epigenetic Mechanisms in Human Disease |
2/15/2005
|
Elias A. Zerhouni, MD |
Future of Medical Imaging |
2/8/2005
|
J. Carl Barrett, PhD |
Biosystems and Cancer: Implications for Cancer Development and Therapy |
2/1/2005
|
Javed Khan, MD |
The Applications of Microarrays and Artificial Intelligence for Diagnosis, Predicting Prognosis and Selection of Therapeutic Targets |
1/25/2005
|
Carter Van Waes, MD, PhD |
Nuclear Factor-kappaB in Regulation of Gene Expression and as a Target for Molecular Therapy |
1/18/2005
|
Beverly Teicher, PhD |
Newer Cell-based Models and Therapeutic Targets Related to Tumor Vasculature |
1/11/2005
|
Louis M. Staudt, MD, PhD |
Molecular Diagnosis and Molecular Targets in Lymphoid Malignancies by Gene Expression Profiling |
1/4/2005
|
Donald S. Coffey, PhD |
What Are the Implications of the Common Denominators of Cancer? |
12/14/2004
|
Dr. Christopher Logothetis |
|
11/30/2004
|
Stephen J. Chanock, MD |
SNPing Away at Cancer |
11/23/2004
|
Judith A. Shell, RN, PhD, A.O.C.N. |
Symptom Management in Cancer Related Sexual Dysfunction |
11/16/2004
|
Phillip A. Dennis, MD, PhD |
Targeting the Akt Pathway for the Prevention or Treatment of Lung Cancer |
11/9/2004
|
Thomas A. Waldmann, MD |
IL2 and IL15: Implications for Immunotherapy and the Design of Molecular Vaccines |
11/2/2004
|
Andrei Kozlov, PhD |
Tumor Markers and Evolution |
10/26/2004
|
Michael B. Sporn, MD |
Chemoprevention of Cancer: New Approaches, New Agents, New Mechanisms |
10/19/2004
|
Allan M. Weissman, MD |
Regulating the RINGs, the Battle for Protein Fate |
10/12/2004
|
James H. Doroshow, MD |
Reactive Oxygen Metabolism and the Anthracycline Antibiotic Cell Death Program |
10/5/2004
|
Judah Folkman, MD |
Can the Angiogenic Switch be Prevented in Human Cancer |
9/21/2004
|
Dr. David Carbone |
Molecular Signatures of Lung Cancer |
7/27/2004
|
Elias A. Zerhouni, MD |
Future of Medical Imaging |
7/20/2004
|
Steven A. Rosenberg, PhD, MD |
The Development of Cell Transfer Immunotherapy for Patients with Cancer |
7/13/2004
|
Andrew von Eschenbach, MD |
Progress Toward Eliminating the Suffering and Death Due to Cancer |
7/6/2004
|
Ronald E. Gress, MD |
The Interface of Cancer Immunotherapy and Chemotherapy |
6/29/2004
|
James C. Yang, MD |
Biological Approaches to the Treatment of Metastatic Renal Cancer |
6/22/2004
|
Ronald D.G. McKay, PhD |
The Importance of Embryonic Stem Cells in Science and Medicine |
6/15/2004
|
Stuart A. Aaronson, MD |
Cancer Targeting in the 21st Century |
6/1/2004
|
V. Craig Jordan, OBE, PhD, D.Sc |
Estrogen-Induced Apoptosis to Kill the Cancer But Not the Patient |
5/25/2004
|
Henry T. Lynch, MD |
Lynch Syndrome (HNPCC): Genetic Counseling, Surveillance, Management, and Molecular Genetics |
5/18/2004
|
Robert B. Diasio, MD |
The Increasing Importance of Pharmacogenetics/Pharmacogenomics in Cancer Chemotherapy: Lessons from 5-Fluorouracil Research |
5/11/2004
|
Axel Ullrich, PhD |
From Gene to Cancer Therapy |
4/27/2004
|
Carl F. Nathan, MD |
Inflammation as a Flow of Information |
4/20/2004
|
Martin Abeloff, MD |
Adjuvant Therapy of Breast Cancer: The Importance of Incremental Gains |
4/13/2004
|
Norman W. Thompson, MD, PhD |
The Screening and Management of Pancreatic Neuroendocrine Tumors in Patients with MEN1 |
4/6/2004
|
Daniel D. Von Hoff, MD |
Pursuing Therapeutic Targets That Aren't There |
2/24/2004
|
Kathryn Zoon, PhD |
Human Interferon Alpha: Clinical Diversity and Still an Enigma |
2/17/2004
|
Richard G. Pestell, MD, PhD |
Nuclear Receptors and Cyclins in Hormone Signaling |
2/10/2004
|
Thomas J. Walsh, MD |
Echinocandins: A New Advance in Infectious Diseases Supportive Care from Bench to Bedside |
2/3/2004
|
V. Craig Jordan, OBE, PhD, DSc |
Estrogen-Induced Apoptosis to Kill the Cancer But Not the Patient |
1/27/2004
|
Albert J. Fornace, Jr, MD
|
The Case for p38 MAP Kinase as a Tumor Suppressor: New Targets for Cancer Therapeutics |
1/20/2004
|
Larry O. Arthur, PhD |
Basic Research Leading to an Inactivated Viral Vaccine |
1/13/2004
|
Michael B. Kastan, MD,PhD |
The ATM Signaling Pathway: Importance in Cancer Development and Therapy |
1/6/2004
|
Jeffrey Schlom, PhD |
Design and Development of Recombinant Vaccines for Cancer Therapy |
12/16/2003
|
Carlos L. Arteaga, MD |
The ErbB Network as a Therapeutic Strategy in Human Neoplasia |
12/9/2003
|
Kenneth W. Kinzler, MD |
Molecular Analyses of Colorectal Cancer |
12/2/2003
|
John M. Goldman, FRCP |
Chronic Myeloid Leukaemia: Some Progress Towards Cure? |
11/25/2003
|
Lorraine J. Gudas, PhD |
Stem Cells, Retinoids, and Cancer Therapy |
11/18/2003
|
Robert Yarchoan, MD |
AIDS Malignancies: Opportunities for the Targeted Therapy of Opportunistic Tumors |
11/4/2003
|
Larry Kwak, MD, PhD |
Translational Development of Therapeutic Lymphoma Vaccines |
10/28/2003
|
Steven K. Libutti, MD |
AIDS Vaccines: Basic Science to Clinical Applications |
10/21/2003
|
Michael B.Sporn |
The NCI: A Bridge for Genesis and Transduction of New Ideas in Cancer Prevention and Treatment |
10/7/2003
|
Peter L. Choyke, MD |
NCI's Molecular Imaging Program |
9/30/2003
|
Ronald G. Crystal, MD |
Genetic Medicine Strategies to Augment Host Defenses Against Cancer |
9/23/2003
|
(1) Lance Liotta, MD, PhD
(2) Emanuel Petricoin, PhD
|
Clinical Proteomics: Application to Early Diagnosis and Individualized Therapy of Cancer |
9/16/2003
|
Shiv Grewal, PhD |
RNAi-mediated Epigenetic Control of Genome: Implications for Cancer Biology |
9/9/2003
|
H. Richard Alexander,MD |
Experience with High Dose Tumor Necrosis Factor in Cancer Treatment Using Vascular and Perfusion Techniques |
7/29/2003
|
Joe W. Gray, PhD |
Cancer Genomics: Recurrent Events, Mechanisms and Targets |
7/22/2003
|
Frank M. Balis, MD |
Central Nervous System Pharmacology of Anti-Cancer Drugs |
7/8/2003
|
Moshe Talpaz, MD |
CML: Evolution of Therapy and Emerging Questions |
7/1/2003
|
John T. Isaacs, PhD |
Rational Drug Therapy for Prostate Cancer Based on Its Unique Biology |
6/24/2003
|
Lee J. Helman, MD |
Metastatic Signalling Pathways in a Mouse Osteosarcoma Model |
6/17/2003
|
Todd R. Golub, MD |
Genomic Information and Cancer |
5/27/2003
|
Rachel Ballard-Barbash, MD |
Energy Balance and Cancer: Risk and Prognosis |
5/20/2003
|
Karen Antman, MD |
New Developments in Sarcomas |
5/13/2003
|
Derek LeRoith, MD, PhD |
The Role of Insulin-like Growth Factors in Cancer |
5/6/2003
|
Anita B. Roberts, PhD |
Smad3: A Major Player in Pathogenetic Effects of TGF-beta |
4/29/2003
|
Michail V. Sitkovsky, PhD |
Tumor Defense Countermeasures: The Anti-Purinergic Strategy for Therapy of Cancer |
4/22/2003
|
Neil Caporaso, MD |
Controversies in the Genetics of Lung Cancer |
4/17/2003
|
Terumi Kohwi-Shigematsu, PhD |
Tissue-specific Nuclear Architecture and Gene Function Regulated by a Single Protein SATB1 |
4/15/2003
|
Ann Thor, MD |
Hormonal and Dietary Modification of Mammary Development and Carcinogenesis Using a Transgenic Model System |
4/1/2003
|
Yves Pommier, MD, PhD |
Targeting DNA Topoisomerase I and Its Downstream Targets for Cancer Therapies |
3/25/2003
|
Thomas Reid, MD |
Aneuploidy and Cancer: Cause or Consequence? |
3/18/2003
|
John M. Coffin, PhD |
HIV Evolution and Drug Resistance |
3/11/2003
|
Gary K. Schwartz, MD |
Development of Cell Cycle Inhibitors for Cancer Therapy |
3/4/2003
|
Louis M. Staudt, MD, PhD |
Molecular Diagnosis and Molecular Targets in Cancer By Gene Expression Profiling |
2/25/2003
|
Emil J. Freireich, M.D., D. Sc. (Hon.) |
Bedside to Bench and Back: The Impact of Therapeutic Research on the Understanding of Cancer Biology |
2/18/2003
|
Yves Pommier, M.D., Ph.D. |
Targeting DNA Topoisomerase I and its Downstream Targets for Cancer Therapies |
2/11/2003
|
Patricia Ganz, M.D.
|
Breast Cancer: A Model for Cancer Survivorship Research |
2/4/2003
|
Issiah Fidler, D.V.M., Ph.D. |
Anit-Vascular Therapy of Cancer Metastasis |